{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:15:35Z","timestamp":1787163335898,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["10\/71\/01"],"award-info":[{"award-number":["10\/71\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Impaired physical performance and frailty are common in older people with advanced chronic kidney disease but it is unclear which metabolic derangements contribute to these impairments. We, therefore, examined associations between renal biochemical markers and both physical performance and frailty in older people with advanced chronic kidney disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Secondary analysis of data from the BiCARB trial, which enrolled non-dialysing patients aged 60 and over, with chronic kidney disease stage 4\/5, with serum bicarbonate\u2009&lt;\u200922\u00a0mmol\/L. Participants undertook the Short Physical Performance Battery, maximum grip strength and six-minute walk test at baseline, 3,\u00a06,\u00a012 and 24\u00a0months. Renal biochemistry (serum creatinine, cystatin C, phosphate, and bicarbonate), haemoglobin, 25-hydroxyvitamin D and NT-pro-B-type natriuretic peptide were measured at baseline. Associations between baseline renal biochemistry and physical performance, and between baseline biochemistry and the monthly rate of change in physical performance were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We analysed data from 300 participants (mean age 74\u00a0years; 86 [29%] women). 148 (49%) were pre-frail, 86 (29%) were frail. In multivariable cross-sectional baseline analyses, only age and BMI were significantly associated with baseline short physical performance battery; age, sex, body mass index, NT-pro-BNP and 25-hydroxyvitamin D were significantly associated with baseline six-minute walk distance. No significant associations were found between biochemical markers and change in physical performance over time, except between baseline 25-hydroxyvitamin D concentration and change in six-minute walk distance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Biochemical markers associated with chronic kidney disease did not consistently associate with baseline physical performance or the rate of change of physical performance measures.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial Registration<\/jats:bold>\n                      : ISRCTN09486651\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s41999-021-00478-4","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T11:02:46Z","timestamp":1615978966000},"page":"943-952","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Associations between frailty, physical performance, and renal biomarkers in older people with advanced chronic kidney disease"],"prefix":"10.1007","volume":"12","clinical-trial-number":[{"clinical-trial-number":"isrctn09486651","registry":"10.18810\/isrctn"}],"author":[{"given":"George","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Avenell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Band","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund J.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta C.","family":"Littleford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McNamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy L.","family":"Soiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Sumukadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1967-0990","authenticated-orcid":false,"given":"Miles D.","family":"Witham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"478_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381:752\u2013762","journal-title":"Lancet"},{"key":"478_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ageing\/afx162","volume":"47","author":"G Kojima","year":"2018","unstructured":"Kojima G, Iliffe S, Walters K (2018) Frailty index as a predictor of mortality: a systematic review and meta-analysis. Age Ageing 47:193\u2013200","journal-title":"Age Ageing"},{"key":"478_CR3","doi-asserted-by":"publisher","first-page":"100960","DOI":"10.1016\/j.arr.2019.100960","volume":"56","author":"AIL Cunha","year":"2019","unstructured":"Cunha AIL, Veronese N, de Melo BS, Ricci NA (2019) Frailty as a predictor of adverse outcomes in hospitalized older adults: a systematic review and meta-analysis. Ageing Res Rev 56:100960","journal-title":"Ageing Res Rev"},{"key":"478_CR4","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1080\/09638288.2016.1212282","volume":"39","author":"G Kojima","year":"2017","unstructured":"Kojima G (2017) Frailty as a predictor of disabilities among community-dwelling older people: a systematic review and meta-analysis. Disabil Rehabil 39:1897\u20131908","journal-title":"Disabil Rehabil"},{"key":"478_CR5","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146\u2013M156","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"478_CR6","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/archinternmed.2012.3020","volume":"172","author":"Y Bao","year":"2012","unstructured":"Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL (2012) Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med 172:1071\u20131077","journal-title":"Arch Intern Med"},{"key":"478_CR7","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s11255-017-1547-5","volume":"49","author":"G Kojima","year":"2017","unstructured":"Kojima G (2017) Prevalence of frailty in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 49:1989\u20131997","journal-title":"Int Urol Nephrol"},{"key":"478_CR8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","volume":"60","author":"RM Collard","year":"2012","unstructured":"Collard RM, Boter H, Schoevers RA, Oude Voshaar RC (2012) Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 60:1487\u20131492","journal-title":"J Am Geriatr Soc"},{"key":"478_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.archger.2016.10.007","volume":"68","author":"R Chowdhury","year":"2017","unstructured":"Chowdhury R, Peel NM, Krosch M, Hubbard RE (2017) Frailty and chronic kidney disease: A systematic review. Arch Gerontol Geriatr 68:135\u2013142","journal-title":"Arch Gerontol Geriatr"},{"key":"478_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1248\/bpb.b19-00513","volume":"42","author":"H Watanabe","year":"2019","unstructured":"Watanabe H, Enoki Y, Maruyama T (2019) Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions. Biol Pharm Bull 42:1437\u20131445","journal-title":"Biol Pharm Bull"},{"key":"478_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.ackd.2017.06.005","volume":"24","author":"JA Kraut","year":"2017","unstructured":"Kraut JA, Madias NE (2017) Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease. Adv Chronic Kidney Dis 24:289\u2013297","journal-title":"Adv Chronic Kidney Dis"},{"key":"478_CR12","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3390\/nu12061814","volume":"12","author":"H Nishi","year":"2020","unstructured":"Nishi H, Takemura K, Higashihara T, Inagi R (2020) Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach. Nutrients 12:1814","journal-title":"Nutrients"},{"key":"478_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12882-015-0189-z","volume":"16","author":"SD Fraser","year":"2015","unstructured":"Fraser SD, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ et al (2015) The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol 16:193","journal-title":"BMC Nephrol"},{"key":"478_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejim.2018.05.030","volume":"56","author":"A Corsonello","year":"2018","unstructured":"Corsonello A, Roller-Wirnsberger R, Di Rosa M, Fabbietti P, Wirnsberger G, Kostka T et al (2018) Estimated glomerular filtration rate and functional status among older people: A systematic review. Eur J Intern Med 56:39\u201348","journal-title":"Eur J Intern Med"},{"key":"478_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s13063-015-0843-6","volume":"16","author":"MD Witham","year":"2015","unstructured":"Witham MD, Band MM, Littleford RC, Avenell A, Soiza RL, McMurdo ME et al (2015) Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial. Trials 16:326","journal-title":"Trials"},{"key":"478_CR16","doi-asserted-by":"crossref","unstructured":"Witham MD, Band M, Ahmed A, Almond MK, Balasubramaniam G, Basnayake K et al; the BiCARB study group. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial. BMC Medicine 2020;18:91.","DOI":"10.1186\/s12916-020-01542-9"},{"key":"478_CR17","doi-asserted-by":"crossref","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461\u201370.","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"478_CR18","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG et al (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49:M85-94","journal-title":"J Gerontol"},{"key":"478_CR19","doi-asserted-by":"crossref","unstructured":"Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability N Engl J Med. 1995;332:556\u201361.","DOI":"10.1056\/NEJM199503023320902"},{"key":"478_CR20","first-page":"919","volume":"132","author":"GH Guyatt","year":"1985","unstructured":"Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW et al (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132:919\u2013923","journal-title":"Can Med Assoc J"},{"key":"478_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ageing\/afr051","volume":"40","author":"HC Roberts","year":"2011","unstructured":"Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C et al (2011) A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 40:423\u2013429","journal-title":"Age Ageing"},{"key":"478_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331","journal-title":"Age Ageing"},{"key":"478_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF00451725","volume":"3","author":"RD Hays","year":"1994","unstructured":"Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB (1994) Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 3:329\u2013338","journal-title":"Qual Life Res"},{"key":"478_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1053\/j.jrn.2016.11.003","volume":"27","author":"SY Lee","year":"2017","unstructured":"Lee SY, Yang DH, Hwang E, Kang SH, Park SH, Kim TW, Lee DH, Park K, Kim JC (2017) The Prevalence, Association, and Clinical Outcomes of Frailty in Maintenance Dialysis Patients. J Ren Nutr 27:106\u2013112","journal-title":"J Ren Nutr"},{"key":"478_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1477-7525-12-27","volume":"12","author":"HN Mansur","year":"2014","unstructured":"Mansur HN, Colugnati FA, Grincenkov FR, Bastos MG (2014) Frailty and quality of life: a cross-sectional study of Brazilian patients with pre-dialysis chronic kidney disease. Health Qual Life Outcomes 12:27","journal-title":"Health Qual Life Outcomes"},{"key":"478_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.arr.2015.04.001","volume":"21","author":"O Theou","year":"2015","unstructured":"Theou O, Cann L, Blodgett J, Wallace LM, Brothers TD, Rockwood K (2015) Modifications to the frailty phenotype criteria: Systematic review of the current literature and investigation of 262 frailty phenotypes in the Survey of Health, Ageing, and Retirement in Europe. Ageing Res Rev 21:78\u201394","journal-title":"Ageing Res Rev"},{"key":"478_CR27","doi-asserted-by":"publisher","first-page":"36618","DOI":"10.1038\/srep36618","volume":"6","author":"E Sato","year":"2016","unstructured":"Sato E, Mori T, Mishima E, Suzuki A, Sugawara S, Kurasawa N et al (2016) Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease. Sci Rep 6:36618","journal-title":"Sci Rep"},{"key":"478_CR28","doi-asserted-by":"crossref","unstructured":"Corsonello A, Roller-Wirnsberger R, Wirnsberger G, \u00c4rnl\u00f6v J, Carlsson AC, Tap L et al. Clinical Implications of Estimating Glomerular Filtration Rate with Three Different Equations Among Older People. Preliminary Results of the Project \"Screening for Chronic Kidney Disease among Older People across Europe (SCOPE)\u201d. J Clin Med. 2020;9:294.","DOI":"10.3390\/jcm9020294"},{"key":"478_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jhn.12394","volume":"30","author":"H Rosendahl-Riise","year":"2017","unstructured":"Rosendahl-Riise H, Spielau U, Ranhoff AH, Gudbrandsen OA, Dierkes J (2017) Vitamin D supplementation and its influence on muscle strength and mobility in community-dwelling older persons: a systematic review and meta-analysis. J Hum Nutr Diet 30:3\u201315","journal-title":"J Hum Nutr Diet"},{"key":"478_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12877-019-1196-x","volume":"19","author":"T Kidd","year":"2019","unstructured":"Kidd T, Mold F, Jones C, Ream E, Grosvenor W, Sund-Levander M et al (2019) What are the most effective interventions to improve physical performance in pre-frail and frail adults? A systematic review of randomised control trials. BMC Geriatr 19:184","journal-title":"BMC Geriatr"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-021-00478-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-021-00478-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-021-00478-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T18:41:22Z","timestamp":1632508882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-021-00478-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1007\/s41999-021-00478-4","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for the BiCARB trial was granted by the East of Scotland NHS Research Ethics Committee (approval 12\/ES\/0023).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants in the BiCARB trial, and the trial was conducted according to the principles of the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}